GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Thermo Fisher Scientific TMO · USD

Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States

S&P 500

Compare

721.63

+3.87%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

34 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 11Strong buy
  • 16Buy
  • 7Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Average target 597.67

Low
520.00
Average
597.67
Median
600.00
High
650.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$48.00bn$50.56bn$53.75bn$57.18bn$59.05bn
Revenue, highest$48.20bn$51.17bn$55.51bn$57.99bn$59.88bn
Revenue, lowest$47.62bn$50.12bn$52.97bn$56.67bn$58.53bn
Earnings per share25.2827.7130.6133.8337.02
Earnings per share, highest25.3829.0232.4134.4537.69
Earnings per share, lowest25.0726.9727.4233.4436.59
Analysts191919915

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast6.475.775.296.515.555.285.156.00
Reported6.686.035.446.575.795.365.156.10
Difference+3.3%+4.5%+2.8%+0.9%+4.4%+1.6%-0.1%+1.7%

Rating changes

Latest broker notes

  • Piper SandlerNeutral
  • Morgan StanleyOverweight
  • RBC CapitalSector Perform
  • BarclaysOverweight
  • Evercore ISI GroupOutperform
  • HSBCBuy → Hold
  • Wells FargoOverweight
  • StifelBuy
  • BairdOutperform
  • BarclaysOverweight
  • Evercore ISI GroupOutperform
  • TD CowenBuy

Recent targets

Latest 12 months

  • UBS730.00
  • CLSA748.00
  • Stifel Nicolaus650.00
  • Piper Sandler600.00
  • Morgan Stanley650.00
  • RBC Capital580.00
  • Jefferies630.00
  • Evercore ISI570.00

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 10.1% a year over 10 years. Return on equity 12.6%.

Model fair value

697.23

From earnings 697.23, from revenue 577.56.

Piotroski score

5 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.